Encyclopedia

  • In vitro metabolism of dehydroepiandrosterone (DHEA) to 7α-hydroxy-DHEA and Δ5-androstene-3β,17β-diol in specific regions of the aging brain from Alzheimer’s and non-demented patients
  • Add time:08/26/2019         Source:sciencedirect.com

    The description of dehydroepiandrosterone (DHEA) as a neuroactive neurosteroid has raised the important question of whether the steroid itself and/or its metabolite(s) are active in the brain. Classical transformations of DHEA in brain and peripheral tissues include its conversion to testosterone and estradiol. In the human brain, the metabolism of DHEA to other metabolites is still poorly understood, particularly in aging people and Alzheimer’s patients. The present study describes the in vitro transformation of DHEA into 7α-hydroxy-DHEA and Δ5-androstene-3β,17β-diol, for the first time in the aging brain of patients with Alzheimer’s disease in comparison with non-demented controls. Formal identification of DHEA metabolites is provided by gas chromatography–mass spectrometry, thus indicating the presence of NADPH-dependent 7α-hydroxylase and 17β-hydroxysteroid oxidoreductase activities. Under our experimental conditions, the synthesis of 7α-hydroxy-DHEA and Δ5-androstene-3β,17β-diol occurs in the frontal cortex, hippocampus, amygdala, cerebellum and striatum of both Alzheimer’s patients and non-demented controls. In both groups of patients, the pattern of DHEA metabolism is similar, but significant higher synthesis of 7α-hydroxy-DHEA in the frontal cortex and Δ5-androstene-3β,17β-diol in the cerebellum and striatum were observed compared with those in other brain regions. In addition, a trend toward a significant negative correlation is found between the density of cortical amyloid deposits and the amount of 7α-hydroxy-DHEA formed in the frontal cortex and that of Δ5-androstene-3β,17β-diol in the hippocampus. Therefore, the biosynthesis of 7α-hydroxy-DHEA and/or Δ5-androstene-3β,17β-diol is likely to regulate DHEA cerebral concentrations and may contribute to the control of DHEA activity in the aging brain including in Alzheimer’s disease.

    We also recommend Trading Suppliers and Manufacturers of (7α,17β)-3-Methoxy-7-Methyl-estra-1,3,5(10)-trien-17-ol (cas 15506-01-1). Pls Click Website Link as below: cas 15506-01-1 suppliers


    Prev:Original articleNew platinum(II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: Design, synthesis, structure–activity relationships and biological evaluation
    Next: Chemical synthesis and biochemical characterization of a biotinylated derivative of 17β-estradiol with a long side chain covalently attached to its C-7α position)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View